The global orthobiologics market is expected to grow to nearly $8 billion by 2016, according to projections from Transparency Market Research.
Four things to know:
1. The orthobiologics market, which was valued at $4.8 billion in 2017, is expected to hit $7.9 billion by 2026. That's a 5.5 percent compound annual growth rate.
2. North America had the largest share in the orthobiologics market in 2017. The trend is projected to continue with the emergence of technologies and because of the continent's high prevalence of sports-related and fall injuries.
3. The rising geriatric population is another key factor in the projected market growth for orthobiologics.
4. Major players in the market include DePuy Synthes, Arthrex, RTI Surgical, Zimmer Biomet and Globus Medical.